cardiometabolic disease program (Lumen Bioscience/Novo Nordisk)
N/A
Report date: 2025/03/17 09:44:32
Base Information
Drug Namecardiometabolic disease program (Lumen Bioscience/Novo Nordisk)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLumen Bioscience Inc
China Registration ClassN/A
Develop Information
Active CompaniesNovo Nordisk A/SLumen Bioscience Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A